Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PURE BIOLOGICS ZY -,10
No Price
Closing Price XWAR 29.04.2026:
2,50 PLN
29.04.2026 15:00
Current Prices from PURE BIOLOGICS ZY -,10
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
WSE
PUR.WA
PLN
29.04.2026 15:00
2,50 PLN
-0,08 PLN
-3,10 %
Share Float & Liquidity
Free Float98,38 %
Shares Float7,87 M
Shares Outstanding8 M
Company Profile for PURE BIOLOGICS ZY -,10 Share
Pure Biologics Spólka Akcyjna, a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurological autoimmune disorders, including neuromyelitis optica and myasthenia gravis. Pure Biologics Spólka Akcyjna was founded in 2010 and is headquartered in Wroclaw, Poland.
